Two novel mutations in the EPM2A gene in a Korean patient with Lafora's progressive myoclonus epilepsy

被引:10
作者
Ki, CS
Kong, SY
Seo, DW
Hong, SB
Kim, HJ
Kim, JW
机构
[1] Sungkyunkwan Univ, Sch Med, Dept Clin Pathol, Samsung Med Ctr,Kangnam Gu, Seoul 135710, South Korea
[2] Sungkyunkwan Univ, Sch Med, Dept Neurol, Seoul 135710, South Korea
关键词
progressive myoclonus epilepsy (PME); Lafora disease; Lafora body; EPM2A; mutation analysis; insertion mutation; missense mutation; Korean;
D O I
10.1007/s100380300006
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The progressive myoclonus epilepsy of the Lafora type (LD; MIM 254780) is a rare autosomal recessive disorder characterized by epilepsy, myoclonus, progressive neurological deterioration, and the presence of periodic acid-Schiff-positive polyglucosan inclusions (Lafora bodies). Mutations in the EPM2A gene have recently been found to cause LD and about 30 or more mutations have been reported thus far. LD is relatively common in countries of the Mediterranean Basin, the Middle East, India, and Pakistan. Although a few sporadic cases with the typical LD phenotype have also been reported in the Far East including Korea and Japan, a recent effort to find mutations in Japanese LD families was not successful. In the present study, we report two novel mutations in a Korean girl with LD; a 1-bp insertion mutation (c.223insC; G75fsX107) in exon 1 and a missense mutation (c.559A>G; T187A) in exon 3 of the EPM2A gene. To our knowledge, this is the first report of a genetically confirmed case of LD in Koreans and also in the Far East.
引用
收藏
页码:51 / 54
页数:4
相关论文
共 13 条
[1]   Advances in the genetics of progressive myoclonus epilepsy [J].
Delgado-Escueta, AV ;
Ganesh, S ;
Yamakawa, K .
AMERICAN JOURNAL OF MEDICAL GENETICS, 2001, 106 (02) :129-138
[2]   Laforin, defective in the progressive myoclonus epilepsy of Lafora type, is a dual-specificity phosphatase associated with polyribosomes [J].
Ganesh, S ;
Agarwala, KL ;
Ueda, K ;
Akagi, T ;
Shoda, K ;
Usui, T ;
Hashikawa, T ;
Osada, H ;
Delgado-Escueta, AV ;
Yamakawa, K .
HUMAN MOLECULAR GENETICS, 2000, 9 (15) :2251-2261
[3]   Genotype-phenotype correlations for EPM2A mutations in Lafora's progressive myoclonus epilepsy:: exon 1 mutations associate with an early-onset cognitive deficit subphenotype [J].
Ganesh, S ;
Delgado-Escueta, A ;
Suzuki, T ;
Francheschetti, S ;
Riggio, C ;
Avanzini, G ;
Rabinowicz, A ;
Bohlega, S ;
Bailey, J ;
Alonso, ME ;
Rasmussen, A ;
Thomson, AE ;
Ochoa, A ;
Prado, AJ ;
Medina, MT ;
Yamakawa, K .
HUMAN MOLECULAR GENETICS, 2002, 11 (11) :1263-1271
[4]   Mutation screening for Japanese Lafora's disease patients:: identification of novel sequence variants in the coding and upstream regulatory regions of EPM2A gene [J].
Ganesh, S ;
Shoda, K ;
Amano, K ;
Uchiyama, A ;
Kumada, S ;
Moriyama, N ;
Hirose, S ;
Yamakawa, K .
MOLECULAR AND CELLULAR PROBES, 2001, 15 (05) :281-289
[5]   Mutational spectrum of the EPM2A gene in progressive myoclonus epilepsy of Lafora:: high degree of allelic heterogeneity and prevalence of deletions [J].
Gómez-Garre, P ;
Sanz, Y ;
de Córdoba, SR ;
Serratosa, JM .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2000, 8 (12) :946-954
[6]  
LEE SH, 1995, KOREAN J NEUROL, V13, P96
[7]   Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy [J].
Minassian, BA ;
Lee, JR ;
Herbrick, JA ;
Huizenga, J ;
Soder, S ;
Mungall, AJ ;
Dunham, I ;
Gardner, R ;
Fong, CG ;
Carpenter, S ;
Jardim, L ;
Satishchandra, P ;
Andermann, E ;
Snead, OC ;
Lopes-Cendes, I ;
Tsui, LC ;
Delgado-Escueta, AV ;
Rouleau, GA ;
Scherer, SW .
NATURE GENETICS, 1998, 20 (02) :171-174
[8]   Mutation spectrum and predicted function of laforin in Lafora's progressive myoclonus epilepsy [J].
Minassian, BA ;
Ianzano, L ;
Meloche, M ;
Andermann, E ;
Rouleau, GA ;
Delgado-Escueta, AV ;
Scherer, SW .
NEUROLOGY, 2000, 55 (03) :341-346
[9]  
Minassian BA, 1999, ANN NEUROL, V45, P262, DOI 10.1002/1531-8249(199902)45:2<262::AID-ANA20>3.0.CO
[10]  
2-9